|
Volumn 8, Issue 6, 1997, Pages 12-
|
New triple combo trial opens.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
DRUG COMBINATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT SELECTION;
UNITED STATES;
VIRUS LOAD;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
NELFINAVIR;
NEVIRAPINE;
PATIENT SELECTION;
REVERSE TRANSCRIPTASE INHIBITORS;
RHODE ISLAND;
SAN FRANCISCO;
STAVUDINE;
VIRAL LOAD;
|
EID: 0031265484
PISSN: 15232883
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|